Year : 2022

Volume : Volume 13

Issue : Issue 6

Address for correspondence :
Dr. Ajay Parihar,
ajaycbct@gmail.com

Abstract

Novel coronavirus infection has been sweeping across the globe since 2019. Various clinical manifestations are seen in coronavirus disease 2019 (COVID-19) patients and there has been a notable rise in the incidence of invasive fungal infections like mucormycosis. The prevalence of mucormycosis in India is being approximately 0.14 cases per 1000 population which is about 80 times the prevalence in developed countries. Conditions causing immunosuppression are closely associated with the development of any fungal infection including mucormycosis and in India, the most important risk factor for developing mucormycosis is diabetes mellitus. Since mucormycosis lacks stereotypical clinical features, it may show resemblances to other diseases affecting the bone and the oral mucosa and early diagnosis is crucial as the infection is rapidly progressive and fatal. The mortality of this infection remains high ranging from 32 to 70% and one of the patient mentioned in this case series died within 2 weeks after diagnosing mucormycosis. Here, we are reporting three cases of mucormycosis in diabetic patients reported during COVID-19 outbreak.

Keywords: Coronavirus disease 2019, Diabetes mellitus, Fungal infections, Maxillary sinus, Mucormycosis.